$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site

(Singapore, 1993-1997 cases followed-up until 2001)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10Total includedDeadAliveComplete FUMedian FU (in months)
No.%No.%No.%
C01-02Tongue1208167.53932.5120100.018.6
C03-06Oral cavity1359368.94231.1135100.017.9
C07-08Salivary gland873034.55765.587100.062.9
C09Tonsil382565.81334.238100.034.4
C11Nasopharynx140465946.974553.11404100.056.9
C12-13Hypopharynx908493.366.790100.010.0
C15Oesophagus44642495.1224.9446100.05.3
C16Stomach2100172782.237317.82100100.08.5
C17Small intestine806378.81721.380100.012.9
C18Colon2501154061.696138.42501100.037.8
C19-20Rectum1753106460.768939.31753100.041.1
C21Anus533973.61426.453100.022.6
C22Liver1550149096.1603.91550100.02.2
C23-24Gall bladder28926190.3289.7289100.05.2
C25Pancreas51249596.7173.3512100.02.6
C30-31Nose/Sinuses714563.42636.671100.034.9
C32Larynx31117455.913744.1311100.045.9
C33-34Lung4253403194.82225.24253100.05.4
C37-38Other thoracic organs633758.72641.363100.039.1
C40-41Bone613963.92236.161100.029.5
C43Melanoma skin604168.31931.760100.031.6
C44Other skin103731130.072670.01037100.067.2
C45Mesothelioma343191.238.834100.06.2
C47+C49Connective tissue1668450.68249.4166100.049.7
C48Peritoneum403075.01025.040100.018.9
C50Breast3204101831.8218668.23204100.064.1
C51Vulva351645.71954.335100.056.1
C53Cervix98441642.356857.7984100.058.4
C54Corpus uteri48312425.735974.3483100.063.6
C56Ovary71829340.842559.2718100.059.0
C60Penis411946.32253.741100.055.0
C61Prostate75245961.029339.0752100.048.9
C62Testis751114.76485.375100.071.8
C64Kidney36921157.215842.8369100.034.6
C65Renal pelvis443170.51329.544100.011.0
C67Urinary bladder49625250.824449.2496100.052.2
C70-72Brain & nervous system29021172.87927.2290100.015.0
C73Thyroid5548315.047185.0554100.072.5
C74Adrenal gland281864.31035.728100.022.6
C81Hodgkin lymphoma732331.55068.573100.069.4
C82-85+C96Non-Hodgkin lymphoma79047259.731840.3790100.023.2
C90Multiple myeloma15913886.82113.2159100.016.1
C91Lymphoid leukaemia20511958.08642.0205100.036.4
C92-94Myeloid leukaemia39032783.86316.2390100.07.7
C95Leukaemia unspecified726691.768.372100.02.3


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Singapore, 1993-1997 cases followed-up until 2001)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Singapore, 1993-1997)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-1997 (Singapore)
- Table7b: Number of cases by cancer site and calendar period (Singapore Cancer Registry, 1968-1997)
- Table8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)
- Table9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)